drugset
drugset / Trial / NCT04159961

Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers

NCT04159961 ↗

Phase 1 Completed 18 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupOpen-labelBasic science

Summary

This is a randomized, open-label, parallel design Phase I clinical trial to evaluate the safety/tolerability and pharmacokinetic of DWJ211 in healthy volunteers

Timeline

Start
2019-12-24
Primary completion
2020-04-21
Completion
2020-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Deoxycholic Acid Small molecule — Subcutaneous

Indications

No indication recorded.